Literature DB >> 15937754

Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study.

Johan Maertens1, Axel Glasmacher, Dominik Selleslag, Angela Ngai, Desmond Ryan, Melissa Layton, Arlene Taylor, Carole Sable, Nicholas Kartsonis.   

Abstract

There has been minimal clinical experience with the use of the Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) for patients receiving echinocandin therapy. We reviewed the experience with the galactomannan ELISA for 17 patients in a study of caspofungin treatment for invasive aspergillosis. The rate of successful outcomes for these patients was similar to that overall for participants in the study. Trends in antigenemia levels correlated with clinical and radiographic findings.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15937754     DOI： 10.1086/430826

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  7 in total

1.  Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Rodrigo Martino; Rocio Parody; Takahiro Fukuda; Johan Maertens; Koen Theunissen; Aloysius Ho; Ghulam J Mufti; Nicolaus Kroger; Arnold R Zander; Dominik Heim; Monika Paluszewska; Dominik Selleslag; Katerina Steinerova; Per Ljungman; Simone Cesaro; Anna Nihtinen; Catherine Cordonnier; Lourdes Vazquez; Monica López-Duarte; Javier Lopez; Rafael Cabrera; Montserrat Rovira; Stefan Neuburger; Oliver Cornely; Ann E Hunter; Kieren A Marr; Hans Jürgen Dornbusch; Hermann Einsele
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

2.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

3.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

4.  Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

Authors:  Maiken Cavling Arendrup; Susanne Perkhofer; Susan J Howard; Guillermo Garcia-Effron; Aimanianda Vishukumar; David Perlin; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

Review 5.  Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.

Authors:  Toine Mercier; Ellen Guldentops; Katrien Lagrou; Johan Maertens
Journal:  Front Microbiol       Date:  2018-04-04       Impact factor: 5.640

Review 6.  Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis.

Authors:  Valério R Aquino; Luciano Z Goldani; Alesssandro C Pasqualotto
Journal:  Mycopathologia       Date:  2007-04-05       Impact factor: 3.785

Review 7.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.